Health misinformation dominates social media. Qualified clinicians have a professional responsibility to engage—here's why it matters, how misinformation spreads, and a practical guide for patients and providers...
When coverage is episodic for therapies that work best with continuity, patients pay the price. A look at persistence, weight cycling, sarcopenic obesity risk, and structural weight bias...
Clinicians and healthcare leaders discuss obesity as a chronic disease, care infrastructure gaps, and how GLP-1 medications may reshape healthcare and consumer behavior...
A preview of how multi-agonist therapies may extend beyond today's "GLP-1" framing and influence long-term obesity care delivery...
GLP-1 RAs are reshaping the treatment landscape for obesity, diabetes, and cardiometabolic disease, yet real-world outcomes often fall short...
Why society, clinicians, and patients themselves must adjust their vocabulary to address weight bias and stigma effectively...
AI should expand clinician capacity and restore the human parts of care, not replace them. Learn how Alnu Health extends clinical guidance...
Why GLP-1 Patients Need More Than a Prescription. The reality is patients need ongoing support to sustain progress...